TipRanks
Go Ultimate55% OFF

Compare Eckert & Ziegler Strahlen und Medizintechnik (EUZ) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:EUZEckert & Ziegler Strahlen und MedizintechnikCHF 11.56CHF 766.70M16.63-9.37%Moderate BuyUnlock the CH:EUZ analyst price target with TipRanks PremiumCH:EUZUnlock the CH:EUZ top-analyst price target with TipRanks Premium
DE:GXIGerresheimerEUR 32.56EUR 1.11B-2.7615.50%NeutralUnlock the DE:GXI analyst price target with TipRanks PremiumCH:EUZ vs DE:GXIUnlock the DE:GXI top-analyst price target with TipRanks Premium
DE:M3VMeVis Medical SolutionsEUR 20.20EUR 37.13M26.84-17.74%―Unlock the DE:M3V analyst price target with TipRanks PremiumCH:EUZ vs DE:M3VUnlock the DE:M3V top-analyst price target with TipRanks Premium
DE:SBSSTRATEC BiomedicalEUR 23.90EUR 273.51M-562.50-0.44%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumCH:EUZ vs DE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium
DE:SHLSiemens Healthineers AGEUR 43.52EUR 47.86B21.66-11.97%Moderate BuyUnlock the DE:SHL analyst price target with TipRanks PremiumCH:EUZ vs DE:SHLUnlock the DE:SHL top-analyst price target with TipRanks Premium
DE:MF6MagForce AGEUR 0.01EUR 89.80K―0.00%―Unlock the DE:MF6 analyst price target with TipRanks PremiumCH:EUZ vs DE:MF6Unlock the DE:MF6 top-analyst price target with TipRanks Premium

Performance Comparison

-60%-40%-20%0%20%40%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:EUZEckert & Ziegler Strahlen und Medizintechnik11.56-1.20-9.37%
DE:GXIGerresheimer32.045.3820.18%
DE:M3VMeVis Medical Solutions20.40-3.31-13.95%
DE:SBSSTRATEC Biomedical22.500.321.43%
DE:SHLSiemens Healthineers AG42.89-4.78-10.03%
DE:MF6MagForce AG―――
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts